EGFR and neoplasm: Epidermal growth factor receptor (EGFR) is commonly expressed on OS cell lines and 90% of primary OS samples, with high expression correlated to large tumor volume, prompting to utilize the anti-EGFR monoclonal antibody cetuximab as a potential therapy [187,188].